alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<PAGE>
                                                                  EXHIBIT 23.1





                             CONSENT OF INDEPENDENT
                          CERTIFIED PUBLIC ACCOUNTANTS

Tri-Union Development Corporation
(formerly Tribo Petroleum Corporation)
Houston, Texas


We hereby consent to the incorporation by reference in Registration Statements
No. 333-66282 and 333-66282-01 on Form S-4 our report dated March 18, 2002,
except for Note 15, which is as of April 1, 2002, relating to the consolidated
financial statements of Tri-Union Development Corporation (formerly Tribo
Petroleum Corporation) which is contained in the Prospectus.

We also consent to the reference to us under the caption "Experts" in the
Prospectus.


                                       BDO Seidman, LLP
Houston Texas
March 29, 2002
Pursuant to 5TH CIR. R. 47.5, the court has determined that this opinion should not *

be published and is not precedent except under the limited circumstances set forth in 5TH CIR.

R. 47.5.4.

IN THE UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

No. 07-60506

Summary Calendar

UNITED STATES OF AMERICA

Plaintiff - Appellee

v.

TIMOTHY L. STACKER

Defendant - Appellant

Appeal from the United States District Court 

for the Northern District of Mississippi

USDC No. 2:05-CR-121-1

Before HIGGINBOTHAM, WIENER, and ELROD, Circuit Judges.

PER CURIAM:*

Timothy Stacker appeals the sentence imposed following his guilty plea

to two counts of being a felon in possession of a firearm and one count of

possession with intent to distribute a mixture and substance containing cocaine

base. Stacker argues that the district court erred by enhancing his sentence

pursuant to U.S.S.G. § 2D1.1(b)(1), which applies where a “dangerous weapon

(including a firearm) was possessed,” because when police searched his house a

United States Court of Appeals

Fifth Circuit

F I L E D

July 22, 2009

Charles R. Fulbruge III

Clerk
No. 07-60506

U.S. v. Armstrong, 550 F.3d 382, 404 (5th Cir. 2008). 1

 U.S.S.G. § 2D1.1, comment 3. 2

 906 F.2d 129, 134 (5th Cir. 1990). 3

 U.S.S.G. § 2D1.1, comment 3 states that the enhancement would not apply if the 4

defendant “had an unloaded hunting rifle in the closet.” That is not the case here. Stacker

had an operational pistol in a room in the house.

2

pistol was found in a separate room from the cocaine and drug paraphernalia.

He argues that the district court erred in finding the weapon was “accessible.”

When reviewing for procedural error in the application of the Guidelines,

we examine the district court's interpretation or application of the Guidelines de

novo, and its factual findings for clear error. A § 2D1.1 enhancement is 1

appropriate if a weapon is present “unless it is clearly improbable that the

weapon was connected with the offense.”2

In United States v. McKeever, this Court affirmed a § 2D1.1 enhancement 3

even though the weapons were not in the same room as the drugs: “While it is

true that none of these weapons was discovered in the laboratory area, the judge

was entitled to infer that they were still ‘present’ within the meaning of

Application Note 3.” Here, the record establishes that an operational .380

caliber pistol was found in Stacker’s residence the day after Stacker had sold

illegal drugs from the residence. It is not clearly improbable that the weapon

was connected with the offense. 

4

AFFIRMED.
(104 So. 918)

#### G. W. SCHMIDT, Adm’r, v. Pearl SHOCKLEY.

(8 Div. 701.)

(Supreme Court of Alabama.

May 21, 1925.)

Appeal from Circuit Court, Colbert County; Chas. P. Almon, Judge.

PER CURIAM.

Appeal dismissed for want of prosecution.
October 31, 2006

Ms. Eileen A. Donovan

Acting Secretary

Commodity Futures Trading Commission
Three Lafayette Center

1155 21* Street, N.W.

Washington, D.C. 20581

Reference File # 2730.01
Rule Certification
Dear Ms. Donovan:

Pursuant to Commission Regulation 40.6(a), the Chicago Board of Trade (CBOT®) hereby
submits the following revised option expiration schedule for Agricultural and Financial options:

- Change the last trading day/expiration for January 2009 agricultural and
financial options from Friday, December 26 to Tuesday, December 23, 2008.

The referenced agricultural options include Corn, Soybean, Soybean Oil, Soybean Meal, Oat,
Rice, Wheat and Soybean Board Crush Spread contracts. The referenced financial options
include U.S. Treasury Bond and 10-Year, 5-Year and 2-Year U.S. Treasury Note contracts.
There is no open interest in any of the referenced contracts.

This revision to the option expiration schedule is designed to minimize holiday-related
scheduling issues in connection with the 2008 Christmas holiday.

There were no opposing views concerning this change.

The CBOT certifies that this change conforms with the Commodity Exchange Act and the rules
thereunder.

Sincerely,

Paul J. Draths
Vice President and Secretary

b103106
Letter Agreement


 Exhibit 10.4 
  
  
 Veridex, LLC 
 a Johnson and Johnson company 
 PO Box 4920 
 33 Technology Drive 
 2nd Floor 
 Warren, NJ 07059 
  
 December 20, 2005 
  
  
 Byron Hewett, 
 CEO Immunicon Corporation 
 3401 Masons Mill Road, Suite 100 
 Huntingdon Valley, PA 19006-3574 
  
 Subject:  Development, License and Supply Agreement between Immunicon Corporation and Ortho-Clinical Diagnostics, Inc. dated August 17, 2000 as modified. 
  
 Dear Byron: 
  
 We propose further modifying the subject Agreement by adding the following milestone (to be 5.2.15). All other terms and conditions of the Agreement shall remain the
same. Please indicate your acceptance by signing in the appropriate space below. 
  
 5.1.15 Five Hundred Thousand Dollars (US$500,000) for participation in the SWOG 0500 study (referred to as the “BRAT Study” by the Parties) in which Immunicon participates as the central testing laboratory
for conducting circulating tumor cell testing and analysis of study patients using CellSearch reagents. Two Hundred Fifty Thousand Dollars (US$250,000) of such total $500,000 shall be payable to Immunicon upon the execution of a binding agreement
between Immunicon and the clinical research coordination body responsible for conducting the BRAT Study (currently identified as SWOG); provided that such agreement establishes that Immunicon is the central testing laboratory providing CellSave
tubes for sample collection, shipping of specimens from collection sites to Immunicon, conducting circulating tumor cell analysis of study patients using CellSearchTM reagents according to Good Clinical Practices and providing results to the appropriate study coordinator. The remaining
Two Hundred Fifty Thousand Dollars ($250,000) of the total $500,000 shall be paid to Immunicon upon enrollment by participating groups of more than half of the number of qualified and eligible patients comprising the targeted study population as
defined in the final BRAT Study protocol at study initiation. The completion date for this milestone is one year after the first patient is enrolled. 
  


			
	December 20, 2005	 	Page 1 of 2








 Veridex, LLC 
  
  

			
	 
		
	By:	 	/s/    Mark Myslinski
	 	 	Mark Myslinski, General Manager


  
 ACCEPTED AND AGREED 
  
 IMMUNICON
CORPORATION 
  
 By: /s/ Byron D. Hewett

  
 Name: Byron D. Hewett 
  
 Title: President and CEO 
  
 Date: December 30, 2005 
  


			
	December 20, 2005	 	Page 2 of 2
Petition for Writ of Mandamus Denied and Memorandum Opinion filed July 

19, 2018.

In The 

Fourteenth Court of Appeals

NO. 14-18-00551-CV

IN RE STEVEN M. CURTICE, Relator 

ORIGINAL PROCEEDING 

WRIT OF MANDAMUS 

 County Court at Law No 2 

Galveston County, Texas 

Trial Court Cause No. 17-FD-1370 

MEMORANDUM OPINION 

On July 6, 2018, relator Steven M. Curtice filed a petition for writ of 

mandamus in this court. See Tex. Gov’t Code Ann. § 22.221 (West Supp. 2017); see 

also Tex. R. App. P. 52. In the petition, relator asks this court to compel the 

Honorable Barbara E. Roberts, presiding judge of the County Court at Law No. 2 of 
2 

Galveston County, to vacate her March 9, 2018 order granting real party-in-interest 

Holly S. Curtice’s petition for bill of review. Relator also filed a motion for stay with 

this court. See Tex. R. App. P. 52.10(a).

Subject to certain exceptions not applicable to this case, to obtain mandamus 

relief, a relator must show both that the trial court clearly abused its discretion and 

that the relator has no adequate remedy by appeal. In re Prudential Ins. Co. of Am., 

148 S.W.3d 124, 135–36 (Tex. 2004) (orig. proceeding). Relator has not shown that 

he is entitled to mandamus relief. We therefore deny relator’s petition for writ of 

mandamus and motion for stay.

PER CURIAM 

Panel consists of Chief Justice Frost and Justices Donovan and Brown.
##### 



Exhibit 32.1
 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
  (1)
    
    The Report fully complies with the requirements of Section 13(a)
or 15(d) of the Securities Exchange Act of 1934; and(2)
    
    The information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations of the
Company.
 /s/ Si Sokol

Si SokolChairman and Chief Executive Officer(Principal Executive Officer)January 25, 2006
 /s/ Matthew C. NolanMatthew C. NolanChief Financial Officer, Treasurer and Secretary(Principal Financial Officer)January 25, 2006
 77
EXHIBIT 32.1


                   CERTIFICATION PURSUANT TO 18 U.S.C. SECTION
                 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE
                           SARBANES-OXLEY ACT OF 2002


I, William Lopshire, the Chief Executive Officer of INTERNATIONAL CARD
ESTABLISHMENT, INC. (the "Company"), certify, pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that to the best of my
knowledge:

(1)  the Annual Report on Form 10-KSB of the Company for the fiscal year ended
     December 31, 2004 (the "Report") fully complies with the requirements of
     Section 13 (a) or 15 (d) of the Securities Exchange Act of 1934 (15 U.S.C.
     78m or 78o(d)); and

(2)  the information contained in the Report fairly presents, in all material
     respects, the financial condition and results of operations of the Company.

A signed original of this written statement required by Section 906 has been
provided to International Card Establishment, Inc. and will be retained by
International Card Establishment, Inc. and furnished to the Securities and
Exchange Commission or its staff upon request.



Date:  May 13, 2005


/s/ WILLIAM LOPSHIRE
______________________________________
    William Lopshire
    Chief Executive Officer
94807.1 

UNITED STATES DISTRICT COURT 

SOUTHERN DISTRICT OF NEW YORK 

____________________________________ 

 ) 

LAWRENCE OBSTFELD, ) 

individually and derivatively ) 

on behalf of TOEV MEDICAL ) Civ. No. 07-5847 (DAB) 

CORPORATION, and ) 

IGNITION VENTURES, INC., ) ECF Case 

 ) 

Plaintiffs, ) 

 ) 

v. ) NOTICE OF MOTION

 ) 

ARTHUR SCHWARTZ, ) 

RONALD SOLAR, ) 

RENAISSANCE BIOMEDICAL, INC., ) 

GLEN LIEBER, and ) 

THERMOPEUTIX, INC., ) 

 ) 

Defendants. ) 

____________________________________) 

 PLEASE TAKE NOTICE that, upon the accompanying Memorandum of Law in 

Support of Defendants Ronald Solar, Renaissance Biomedical, Inc., Glen Lieber, and 

ThermopeutiX, Inc.’s Motion to Dismiss, and the accompanying Declaration of Glen 

Lieber in support thereof, Defendants Ronald Solar, Renaissance Biomedical, Inc., Glen 

Lieber, and ThermopeutiX, Inc. (the “Moving Defendants”), by their undersigned 

counsel, hereby move this Court, located at 500 Pearl Street, New York, New York, for 

an Order pursuant to Fed. R. Civ. P. 12(b)(1), 12(b)(2), 12(b)(6) and 23.1 dismissing 

Case 1:07-cv-05847-DAB Document 20 Filed 08/24/2007 Page 1 of 2
 2 94807.1 

Plaintiffs’ Amended Complaint with prejudice and in its entirety. 

 The Moving Defendants respectfully request oral argument on this motion. 

Dated: August 24, 2007 

 New York, New York 

CONSTANTINE CANNON LLP 

 By: s/ Kerin E. Coughlin___ 

 Kerin E. Coughlin 

 Stacey Anne Mahoney 

 450 Lexington Avenue, 17th Floor 

 New York, New York 10017 

 Phone: (212) 350-2700 

 Fax: (212) 350-2701 

 kcoughlin@constantinecannon.com 

 FREDRIKSON & BYRON, P.A. 

Laurie J. Miller (pro hac vice pending) 

 200 Sixth Street, Suite 4000

 Minneapolis, Minnesota 55402

Phone: (612) 492-7000 

 Fax: (612) 492-7077 

 lmiller@fredlaw.com 

Attorneys for Defendants Ronald Solar, 

Renaissance Biomedical, Inc., Glen Lieber 

and ThermopeutiX, Inc.

Case 1:07-cv-05847-DAB Document 20 Filed 08/24/2007 Page 2 of 2
Exhibit 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS
ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Dr. Adya S. Tripathi, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002, that the Quarterly Report of Tripath Technology Inc. on Form 10-Q for the quarter ended March 31, 2006 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information
contained in such Form 10-Q fairly presents in all material respects the financial condition and results of operations of Tripath Technology Inc.



|       |  |                                                
|------ |  | -----------------------------------------------
|       | 
|By:    |  | /s/    ADYA S. TRIPATHI                        
|Name:  |  | Dr. Adya S. Tripathi                           
|Title: |  | Chairman, President and Chief Executive Officer

Date: May 9, 2006

I, Jeffrey L. Garon, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of Tripath Technology Inc. on Form 10-Q for
the quarter ended March 31, 2006 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Form 10-Q fairly presents in all material respects the financial
condition and results of operations of Tripath Technology Inc.



|       |  |                                                    
|------ |  | ---------------------------------------------------
|       | 
|By:    |  | /s/    JEFFREY L. GARON                            
|Name:  |  | Jeffrey L. Garon                                   
|Title: |  | Vice President, Finance and Chief Financial Officer

Date: May 9, 2006
Exhibit 13.2





CERTIFICATION PURSUANT TO 18 U.S.C.


Certification Pursuant to 18 U.S.C. Section 1350 As Adopted Pursuant to Section


906 of the Sarbanes-Oxley Act of 2002









In connection with the Annual Report on Form 20-F/A of Oxford Investments Holdings Inc., a company organized under the laws ofunder the laws of Ontario, Canada (the “Company”), for the period ending December 31, 2010 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned officers of the Company certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to such officer’s knowledge, that:





1.

the Report fully complies, in all material respects, with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and





2.

the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of, and for, the periods presented in the Report.






By:    /S/    Michael Donaghy
 Michael Donaghy
 Chief Financial Officer
 
 Date: November 21, 2011
Exhibit 31.2



OMNI ENERGY SERVICES CORP.

A LOUISIANA CORPORATION

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER

SECTION 302 CERTIFICATION



I, G. Darcy Klug, certify that:



1. I have reviewed this quarterly report on Form 10-Q of OMNI Energy Services Corp., a Louisiana corporation (the registrant);



2. Based on my knowledge, this report does not contain any untrue statement
of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;



3. Based on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;



4. The registrants other certifying officer and I, are responsible for
establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:



a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our
supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being
prepared;



b) Evaluated the effectiveness of
the registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and



c) Disclosed in this report any change in the
registrants internal control over financial reporting that occurred during the registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is
reasonably likely to materially affect, the registrants internal control over financial reporting; and



5. The registrants other certifying officer and I have disclosed, based on our most recent evaluation, to the registrants auditors and the
audit committee of the registrants board of directors (or persons performing the equivalent functions):



a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are
reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information; and



b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants
internal controls over financial reporting.



Date: August 15,
2005



|                                   
|-----------------------------------
|/s/ G. Darcy Klug                  
|G. Darcy Klug                      
|Interim Principal Financial Officer
Case 1:07-cv-05861-RMB-GWG Document 37-11 Filed 01/11/2008 Page 1 of 8
Case 1:07-cv-05861-RMB-GWG Document 37-11 Filed 01/11/2008 Page 2 of 8
Case 1:07-cv-05861-RMB-GWG Document 37-11 Filed 01/11/2008 Page 3 of 8
Case 1:07-cv-05861-RMB-GWG Document 37-11 Filed 01/11/2008 Page 4 of 8
Case 1:07-cv-05861-RMB-GWG Document 37-11 Filed 01/11/2008 Page 5 of 8
Case 1:07-cv-05861-RMB-GWG Document 37-11 Filed 01/11/2008 Page 6 of 8
Case 1:07-cv-05861-RMB-GWG Document 37-11 Filed 01/11/2008 Page 7 of 8
Case 1:07-cv-05861-RMB-GWG Document 37-11 Filed 01/11/2008 Page 8 of 8
UNITED STATES DISTRICT COURT 

SOUTHERN DISTRICT OF NEW YORK 

IN RE WORLD TRADE CENTER 

LOWER MANHATTAN DISASTER 

SITE LITIGATION 

21MC102(AKH)

CIRILO ENCALADA (AND WIFE, MELVA ENCALADA,

Plaintiff(s), 

-against100 WALL STREET COMPANY LLC, et al. 

Defendants. 

07CV4465(AKH)

NOTICE OF ADOPTION BY 

2 BROADWAY LLC OF 

ANSWER TO MASTER 

COMPLAINT

PLEASE TAKE NOTICE that defendant 2 BROADWAY LLC (hereinafter “2 

Broadway”), as and for its response to the allegations set forth in the Complaint by Adoption 

(Check-Off Complaint) related to the Master Complaint adding new defendants not previously 

served filed in the above-referenced action, herein adopts 2 Broadway’s Answer to Master 

Complaint dated August 3, 2007, which was filed in the matter of In re World Trade Center 

Lower Manhattan Disaster Site Litigation, 21 MC 102 (AKH). 2 BROADWAY has filed a 

Master Disclosure of Interested Parties in 21 MC 102 (AKH), and as such, is exempt from 

having to file such a disclosure in this specific matter, pursuant to the provisions of Case 

Management Order No. 4 (¶ J(2)). 

PLEASE TAKE FURTHER NOTICE THAT defendant, 2 Broadway reserves its right 

to assert any defenses to which it is entitled, including but not limited to those enumerated in 

Case Management Order No. 4 (¶¶ D(1)-(5)). 

Case 1:07-cv-04465-AKH Document 26 Filed 12/05/2007 Page 1 of 3
WHEREFORE, 2 Broadway demands judgment dismissing the above-captioned action 

as against it, together with its costs and disbursements. 

Dated: New York, New York 

 December 5, 2007 

HARRIS BEACH PLLC 

Attorneys for Defendant 

2 BROADWAY LLC 

 /s/ 

 Stanley Goos, Esq. (SG 7062) 

100 Wall Street, 23rd Floor 

New York, New York 10005 

(212) 687-0100 

TO: 

Paul Napoli, Esq. 

Worby Groner Edelman & Napoli Bern LLP 

115 Broadway, 12th Floor 

New York, New York 10006 

Robert A. Grochow, Esq. 

Robert A. Grochow, P.C. 

233 Broadway, 5th Floor 

New York, New York 10279 

Gregory J. Cannata, Esq. 

Law Offices of Gregory J. Cannata 

233 Broadway, 5th Floor 

New York, New York 10279 

Liaison Counsel for Plaintiff

James E. Tyrrell, Esq. 

Joseph Hopkins, Esq. 

Patton Boggs LLP 

One Riverfront Plaza, 6th Floor 

Newark, New Jersey 07102 

Thomas Egan, Esq. 

Flemming Zulack Williamson Zauderer LLP 

One Liberty Plaza 

New York, New York 10006 

Liaison Counsel for the Defendants 

All Counsel via ECF 

Case 1:07-cv-04465-AKH Document 26 Filed 12/05/2007 Page 2 of 3
CERTIFICATION AS TO SERVICE

The undersigned certifies that on December 5, 2007, I caused to be filed and 

served the following document electronically via the Court’s ECF system upon the parties: 

1. Notice of 2 Broadway LLC’s Adoption of Answer to Master Complaint. 

Dated: December 5, 2007 

 /s/ 

 Stanley Goos, Esq. (SG 7062) 

Case 1:07-cv-04465-AKH Document 26 Filed 12/05/2007 Page 3 of 3
EXHIBIT 32.2








CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906


OF THE SARBANES-OXLEY ACT OF 2002





In connection with the Amendment No. 1 to the Annual Report on Form 10-K of Songzai International Holding Group, Inc. (the “Company”) for the period ended December 31, 2009 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Weiwei Li, Chief Financial Officer, certify, solely for purposes of Title 18, Chapter 63, Section 1350 of the United States Code, that to my knowledge :





(1)
the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and





(2)
the information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.





/s/ Weiwei LiWeiwei LiChief Financial Officer





Dated: June 21, 2010
Case 1:07-cv-05371-AKH Document 11 Filed 08/16/2007 Page 1 of 4
Case 1:07-cv-05371-AKH Document 11 Filed 08/16/2007 Page 2 of 4
Case 1:07-cv-05371-AKH Document 11 Filed 08/16/2007 Page 3 of 4
Case 1:07-cv-05371-AKH Document 11 Filed 08/16/2007 Page 4 of 4